Immunovant, Inc. · NASDAQ:IMVT
Roivant Sciences Ltd. reported a 55.90% stake in Immunovant, Inc. (Schedule 13D/A)
Event Dec 12, 2025 · Filed Dec 12, 2025
Roivant Sciences Ltd. reported a 55.90% stake in Immunovant, Inc., 113,327,007 shares, with active intent on Dec 12, 2025. Filed Dec 12, 2025 (Schedule 13D/A).
- Stake
- 55.90%
- Shares
- 113,327,007
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Roivant Sciences Ltd. | 55.90% | 113,327,007 |
Source
Related
- Immunovant, Inc.
- Roivant Sciences Ltd.
- Immunovant, Inc. shareholders
- Schedule 13D/A · Roivant Sciences Ltd. · Apr 21, 2025
- Schedule 13D/A · Roivant Sciences Ltd. · Jan 15, 2025
- Form 4 · Gloria Melanie · Oct 9, 2026
- Form 4 · Stout Jay S · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Oct 9, 2026
- Form 4 · Venker Eric · Oct 5, 2026
- Form 4 · Van Tuyl Christopher · Sep 25, 2026